Analysis of chronic kidney disease epidemiology in Kazakhstan using nationwide data for 2014–2020 and forecasting future trends of prevalence and mortality for 2030

References

• Bikbov B, Purcell CA, Levey AS, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):1–12. doi: 10.1016/S0140-6736(20)30045-3.
   PubMed Web of Science ®Google Scholar
• Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392(10159):2052–2090. doi: 10.1016/S0140-6736(18)31694-5.
   PubMed Web of Science ®Google Scholar
• Couser WG, Remuzzi G, Mendis S, et al. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258–1270. doi: 10.1038/ki.2011.368.
   PubMed Web of Science ®Google Scholar
• Matsushita K, Coresh J, Sang Y, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015;3(7):514–525. doi: 10.1016/S2213-8587(15)00040-6.
   PubMed Web of Science ®Google Scholar
• Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–2081.
   PubMed Web of Science ®Google Scholar
• Gaipov A, Issanov A, Kadyrzhanuly K, et al. Epidemiology of dialysis-treated end-stage renal disease patients in Kazakhstan: data from Nationwide Large-Scale Registry 2014–2018. BMC Nephrol. 2020;21(1):407. doi: 10.1186/s12882-020-02047-6.
   PubMed Web of Science ®Google Scholar
• Gusmanov A, Zhakhina G, Yerdessov S, et al. Review of the research databases on population-based registries of Unified Electronic Healthcare System of Kazakhstan (UNEHS): possibilities and limitations for epidemiological research and real-world evidence. Int J Med Inform. 2022;170:104950. doi: 10.1016/j.ijmedinf.2022.104950.
   PubMed Web of Science ®Google Scholar
• Ministry on National economy of the Republic of Kazakhstan Committee on Statistics. Demographic yearbook of Kazakhstan 2022. Astana; 2023.
   Google Scholar
• Carrero JJ, Hecking M, Chesnaye NC, et al. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14(3):151–164. doi: 10.1038/nrneph.2017.181.
   PubMed Web of Science ®Google Scholar
• Goldberg I, Krause I. The role of gender in chronic kidney disease. Eur Med J. 2016;1(2):58–64. doi: 10.33590/emj/10312319.
   Google Scholar
• Arias E, Tejada-Vera B, Ahmad F, et al. Provisional life expectancy estimates for 2020; 2021. doi: 10.15620/cdc:118999.
   Google Scholar
• Glassock R, Delanaye P, El Nahas M. An age-calibrated classification of chronic kidney disease. JAMA. 2015;314(6):559–560. doi: 10.1001/jama.2015.6731.
   PubMed Web of Science ®Google Scholar
• O’Hare AM, Choi AI, Bertenthal D, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007;18(10):2758–2765. doi: 10.1681/ASN.2007040422.
   PubMed Web of Science ®Google Scholar
• Khurana KK, Navaneethan SD, Arrigain S, et al. Serum testosterone levels and mortality in men with CKD stages 3–4. Am J Kidney Dis. 2014;64(3):367–374. doi: 10.1053/j.ajkd.2014.03.010.
   PubMed Web of Science ®Google Scholar
• Crews DC, Kuczmarski MF, Miller Iii ER, et al. Dietary habits, poverty, and chronic kidney disease in an urban population. J Ren Nutr. 2015;25(2):103–110. doi: 10.1053/j.jrn.2014.07.008.
   PubMed Web of Science ®Google Scholar
• Verhave JC, Hillege HL, Burgerhof JGM, et al. Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women. J Am Soc Nephrol. 2003;14(5):1330–1335. doi: 10.1097/01.asn.0000060573.77611.73.
   PubMed Web of Science ®Google Scholar
• Murphy D, McCulloch CE, Lin F, et al. Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med. 2016;165(7):473–481. doi: 10.7326/M16-0273.
   PubMed Web of Science ®Google Scholar
• Yang C, Wang H, Zhao X, et al. CKD in China: evolving spectrum and public health implications. Am J Kidney Dis. 2020;76(2):258–264. doi: 10.1053/j.ajkd.2019.05.032.
   PubMed Web of Science ®Google Scholar
• Gaipov A, Galiyeva D, Gusmanov A, et al. Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from Unified National Electronic Health System 2014–2019. BMC Endocr Disord. 2022;22(1):275.
   PubMed Web of Science ®Google Scholar
• Yerdessov S, Kadyrzhanuly K, Sakko Y, et al. Epidemiology of arterial hypertension in Kazakhstan: data from Unified Nationwide Electronic Healthcare System 2014–2019. J Cardiovasc Dev Dis. 2022;9(2):52. doi: 10.3390/jcdd9020052.
   PubMed Web of Science ®Google Scholar
• Zhakhina G, Zhalmagambetov B, Gusmanov A, et al. Incidence and mortality rates of strokes in Kazakhstan in 2014–2019. Sci Rep. 2022;12(1):16041. doi: 10.1038/s41598-022-20302-8.
   PubMed Web of Science ®Google Scholar
• The Global Adult Tobacco Survey. The Republic of Kazakhstan 2019. Executive summary. Second round. Astana; 2019.
   Google Scholar
• Xu X, Nie S, Ding H, et al. Environmental pollution and kidney diseases. Nat Rev Nephrol. 2018;14(5):313–324. doi: 10.1038/nrneph.2018.11.
   PubMed Web of Science ®Google Scholar
• Al-Aly Z, Bowe B. Air pollution and kidney disease. Clin J Am Soc Nephrol. 2020;15(3):301–303. doi: 10.2215/CJN.16031219.
   PubMed Web of Science ®Google Scholar
• Wu M-Y, Lo W-C, Chao C-T, et al. Association between air pollutants and development of chronic kidney disease: a systematic review and meta-analysis. Sci Total Environ. 2020;706:135522. doi: 10.1016/j.scitotenv.2019.135522.
   PubMed Web of Science ®Google Scholar
• IQAir world’s most polluted countries in 2019—PM2.5 ranking. Air Visual; 2022. Available from: https://www.iqair.com/world-most-polluted-countries
   Google Scholar
• Ormanova G, Karaca F, Kononova N. Analysis of the impacts of atmospheric circulation patterns on the regional air quality over the geographical center of the Eurasian continent. Atmos Res. 2020;237:104858. doi: 10.1016/j.atmosres.2020.104858.
   Web of Science ®Google Scholar
• Assanov D, Zapasnyi V, Kerimray A. Air quality and industrial emissions in the cities of Kazakhstan. Atmosphere. 2021;12(3):314. doi: 10.3390/atmos12030314.
   Web of Science ®Google Scholar
• Ministry of Health of the Republic of Kazakhstan. Clinical protocol for diagnosis and treatment: chronic kidney disease in adults. Protocol 154; 2021. Available from: https://diseases.medelement.com/disease/хроническая-болезнь-почек-у-взрослых-кп-рк-2021/16997
   Google Scholar
• National Institute for Health and Care Excellence Guideline. Chronic kidney disease: assessment and management; 2021. Available from: https://www.nice.org.uk/guidance/ng203/resources/chronic-kidney-disease-assessment-and-management-pdf-66143713055173
   Google Scholar
• Ministry of Health of the Republic of Kazakhstan. Order on approval of the standard for organizing the provision of nephrological care to the population in the Republic of Kazakhstan. Astana; 2014.
   Google Scholar
• Popp B, Ekici AB, Knaup KX, et al. Prevalence of hereditary tubulointerstitial kidney diseases in the German Chronic Kidney Disease Study. Eur J Hum Genet. 2022;30(12):1413–1422. doi: 10.1038/s41431-022-01177-9.
   PubMed Web of Science ®Google Scholar
• Chanouzas D, Ball S. Tubulo-interstitial disorders. Medicine. 2019;47(10):649–653. doi: 10.1016/j.mpmed.2019.07.003.
   Google Scholar
• Ku E, Lee BJ, Wei J, et al. Hypertension in CKD: core curriculum 2019. Am J Kidney Dis. 2019;74(1):120–131. doi: 10.1053/j.ajkd.2018.12.044.
   PubMed Web of Science ®Google Scholar
• Saran R, Robinson B, Abbott KC, et al. US Renal Data System 2017 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2018;71(3 Suppl. 1):A7. doi: 10.1053/j.ajkd.2018.01.002.
   PubMed Web of Science ®Google Scholar
• Kittiskulnam P, Thokanit NS, Katavetin P, et al. The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: a nationwide study. PLOS One. 2018;13(5):e0196332. doi: 10.1371/journal.pone.0196332.
   PubMed Web of Science ®Google Scholar
• Jitraknatee J, Ruengorn C, Nochaiwong S. Prevalence and risk factors of chronic kidney disease among type 2 diabetes patients: a cross-sectional study in primary care practice. Sci Rep. 2020;10(1):6205. doi: 10.1038/s41598-020-63443-4.
   PubMed Web of Science ®Google Scholar
• Major RW, Cheng MRI, Grant RA, et al. Cardiovascular disease risk factors in chronic kidney disease: a systematic review and meta-analysis. PLOS One. 2018;13(3):e0192895. doi: 10.1371/journal.pone.0192895.
   PubMed Web of Science ®Google Scholar
• Koye DN, Magliano DJ, Nelson RG, et al. The global epidemiology of diabetes and kidney disease. Adv Chronic Kidney Dis. 2018;25(2):121–132. doi: 10.1053/j.ackd.2017.10.011.
   PubMed Web of Science ®Google Scholar
• Birkeland KI, Bodegard J, Eriksson JW, et al. Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: a large multinational cohort study. Diabetes Obes Metab. 2020;22(9):1607–1618. doi: 10.1111/dom.14074.
   PubMed Web of Science ®Google Scholar
• Pyram R, Kansara A, Banerji MA, et al. Chronic kidney disease and diabetes. Maturitas. 2012;71(2):94–103. doi: 10.1016/j.maturitas.2011.11.009.
   PubMed Web of Science ®Google Scholar
• Navaneethan SD, Schold JD, Jolly SE, et al. Diabetes control and the risks of ESRD and mortality in patients with CKD. Am J Kidney Dis. 2017;70(2):191–198. doi: 10.1053/j.ajkd.2016.11.018.
   PubMed Web of Science ®Google Scholar
• Turkmen A, Sumnu A, Cebeci E, et al. Epidemiological features of primary glomerular disease in Turkey: a multicenter study by the Turkish Society of Nephrology Glomerular Diseases Working Group. BMC Nephrol. 2020;21(1):481. doi: 10.1186/s12882-020-02134-8.
   PubMed Web of Science ®Google Scholar
• Kim HW, Park JT, Joo YS, et al. Systolic blood pressure and chronic kidney disease progression in patients with primary glomerular disease. J Nephrol. 2021;34(4):1057–1067. doi: 10.1007/s40620-020-00930-x.
   PubMed Web of Science ®Google Scholar
• House AA, Wanner C, Sarnak MJ, et al. Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019;95(6):1304–1317. doi: 10.1016/j.kint.2019.02.022.
   PubMed Web of Science ®Google Scholar
• Tuegel C, Bansal N. Heart failure in patients with kidney disease. Heart. 2017;103(23):1848–1853. doi: 10.1136/heartjnl-2016-310794.
   PubMed Web of Science ®Google Scholar
• Kara AV, Gungor O. Screening and diagnosing cardiovascular disease in chronic kidney disease. In: Arıcı M, edtior. Management of chronic kidney disease: a clinician’s guide. Springer; 2023. p. 157–170. doi: 10.1007/978-3-031-42045-0_12.
   Google Scholar
• Jürgen F. Cardiovascular disease in patients with chronic kidney disease. Herz. 2020;45(2):122–128.
   PubMed Web of Science ®Google Scholar
• Ghoshal S, Freedman BI. Mechanisms of stroke in patients with chronic kidney disease. Am J Nephrol. 2019;50(4):229–239. doi: 10.1159/000502446.
   PubMed Web of Science ®Google Scholar
• Pelaia C, Pastori D, Armentaro G, et al. Predictors of renal function worsening in patients with chronic obstructive pulmonary disease (COPD): a multicenter observational study. Nutrients. 2021;13(8):2811. doi: 10.3390/nu13082811.
   PubMed Web of Science ®Google Scholar
• Trudzinski FC, Alqudrah M, Omlor A, et al. Consequences of chronic kidney disease in chronic obstructive pulmonary disease. Respir Res. 2019;20(1):151. doi: 10.1186/s12931-019-1107-x.
   PubMed Web of Science ®Google Scholar
• Wong F, O’Leary JG, Reddy KR, et al. Acute kidney injury in cirrhosis: baseline serum creatinine predicts patient outcomes. Am J Gastroenterol. 2017;112(7):1103–1110. doi: 10.1038/ajg.2017.122.
   PubMed Web of Science ®Google Scholar
• Cholongitas E, Ioannidou M, Goulis I, et al. Comparison of creatinine and cystatin formulae with 51Chromium-ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis. J Gastroenterol Hepatol. 2017;32(1):191–198. doi: 10.1111/jgh.13446.
   PubMed Web of Science ®Google Scholar
• Paik J, Golabi P, Younoszai Z, et al. Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease. Liver Int. 2019;39(2):342–352. doi: 10.1111/liv.13992.
   PubMed Web of Science ®Google Scholar
• Hoerger TJ, Simpson SA, Yarnoff BO, et al. The future burden of CKD in the United States: a simulation model for the CDC CKD initiative. Am J Kidney Dis. 2015;65(3):403–411. doi: 10.1053/j.ajkd.2014.09.023.
   PubMed Web of Science ®Google Scholar
• Wong LY, Liew AST, Weng WT, et al. Projecting the burden of chronic kidney disease in a developed country and its implications on public health. Int J Nephrol. 2018;2018:5196285–5196289. doi: 10.1155/2018/5196285.
   PubMed Web of Science ®Google Scholar